Complications

Complication
Timeframe
Likelihood
short term
high

Commonly associated with chemotherapy regimens.

long term
high

More likely with higher doses of anthracyclines. [ Cochrane Clinical Answers logo ]

Evaluation of ventricular function should be carried out if an anthracycline (e.g., doxorubicin) or trastuzumab is being considered as treatment.[52][53]

The combination of an anthracycline with trastuzumab is not recommended as it may lead to increased cardiac toxicity.

Caution with dosing and patient selection is important.

long term
high

A recognised common adverse effect of cancer and its treatment.

long term
medium

Trastuzumab is associated with a low risk of cardiotoxicity when used alone, but risk increases in combination with anthracyclines.

Evaluation of ventricular function should be carried out if an anthracycline (e.g., doxorubicin) or trastuzumab is being considered as treatment.[52][53]

The combination of an anthracycline with trastuzumab is not recommended as it may lead to increased cardiac toxicity.

Caution with dosing and patient selection is important.

long term
medium

People taking aromatase inhibitors who have osteoporosis require calcium, vitamin D, and bisphosphonate therapy.

Bisphosphonates are also often prescribed to people with osteopenia who are receiving aromatase inhibitors.

Vitamin D and calcium are given to people on aromatase inhibitor therapy who do not have osteoporosis.

Osteoporosis

variable
high

Bone is the most common site of breast cancer metastases, and these will develop in approximately 70% of patients with MBC.[186]

Patients with bone metastases may have pain and/or pathological fractures.

Palliative radiotherapy may relieve pain from bone metastases.

There are 2 bone-seeking radioisotopes, strontium and samarium, which can be injected intravenously to relieve pain from diffuse bone disease.

The bisphosphonates disodium pamidronate and zoledronic acid, when given to patients with bone metastases, reduce the likelihood of hypercalcaemia and the need for palliative radiation.

variable
medium

Pleural effusions are one of the most common causes of shortness of breath.[47]

May also be a sign of lung metastasis.

Pleural effusions can be relieved by chest tube with pleurodesis, usually using talc to create an inflammatory response that obliterates the pleural space.

variable
medium

A sign of generalised disease.

Commonly related to decreased appetite.

variable
medium

Possible brain or peripheral nervous system metastases.

Surgery and postoperative radiation therapy may be options for patients with favourable prognosis and one or few (2-4) brain metastases.[143]​ Patients with progressive systemic disease at time of brain metastasis diagnosis should be offered HER2-targeted therapy. Tucatinib (a tyrosine kinase inhibitor) plus trastuzumab and capecitabine may be considered in patients whose disease has progressed on ≥1 HER2-directed therapy for metastatic disease.[143]

variable
low

May be due to bone metastases (vertebral column) or metastases to the spinal cord.

Treatment of spinal metastasis is largely palliative. Historically, treatment has consisted of corticosteroids, surgery (decompressive laminectomy/vertebrectomy), and radiation.

variable
low

Due to gastrointestinal metastases.

Management is surgical.

Use of this content is subject to our disclaimer